Keyphrases
Chronic Rhinosinusitis
100%
Nasal Polyposis
50%
Asthma
25%
Treatment Options
25%
Response to Therapy
12%
Medical Treatment
12%
Pathophysiology
12%
United States
12%
Th2 Cytokines
12%
Improved Outcomes
12%
Pharmacotherapy
12%
Interleukin-4 (IL-4)
12%
Interleukin-13 (IL-13)
12%
Pathophysiologic
12%
Asthma Management
12%
Therapeutic Target
12%
Mast Cells
12%
Inflammatory Conditions
12%
Eosinophils
12%
Randomized Double-blind Placebo-controlled Study
12%
Inflammatory Pathways
12%
Related Disorders
12%
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
12%
Clinical Manifestations
12%
Direct Therapy
12%
Biologic Therapy
12%
Basophils
12%
Tissue Infiltration
12%
Interleukin-5 (IL-5)
12%
Disease Subtypes
12%
United Europe
12%
Immunoglobulin E
12%
Emerging Therapeutics
12%
Sinonasal mucosa
12%
Clinical Pathophysiology
12%
Variable Clinical Manifestation
12%
Medicine and Dentistry
Biological Product
100%
Chronic Rhinosinusitis
100%
Nasal Polyp
55%
Asthma
33%
Diseases
22%
Biological Marker
22%
Pathophysiology
22%
Drug Therapy
11%
Combination Therapy
11%
Serositis
11%
Cytokine
11%
Placebo-Controlled Study
11%
Biological Therapy
11%
Mucosa
11%
Eosinophil
11%
Interleukin 13
11%
Mast Cell
11%
Basophil
11%
Immunoglobulin E
11%
Interleukin 4
11%
Interleukin 5
11%
Immunology and Microbiology
Biological Product
100%
Asthma
100%
Immunoglobulin E
33%
Mast Cell
33%
Basophil Granulocyte
33%
Eosinophil Granulocyte
33%
Interleukin 13
33%
Mucosa
33%
Cytokine
33%
Interleukin 4
33%
Interleukin 5
33%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Product
100%
Chronic Rhinosinusitis
100%
Nose Polyp
55%
Asthma
33%
Biological Marker
22%
Disease
22%
Pathophysiology
22%
Pharmacotherapy
11%
Cytokine
11%
Placebo-Controlled Study
11%
Interleukin 4
11%
Combination Therapy
11%
Inflammation
11%
Interleukin 13
11%
Immunoglobulin E
11%
Interleukin 5
11%